Determination of benzodiazepines in oral fluid using LC-MS-MS

Journal of Analytical Toxicology

Volumn 31, Issue 9, 2007, Pages 596-600

  Moore, Christine ^a   Coulter, Cynthia ^a   Crompton, Katherine ^a   Zumwalt, Michael ^b  

^a Immunalysis Corporation   (United States)

^b AGILENT TECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; LORAZEPAM; MIDAZOLAM; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; TEMAZEPAM; TRIAZOLAM;

ARTICLE; CALIBRATION; DEVICE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION;

EID: 37349004757     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.9.596     Document Type: Article

References (15)

1. J.M. Cook, R. Marshall, C. Masci, and J.C. Coyne. Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study. J. Gen. Intern. Med. 22(3): 303-307 (2007).
2. A.W. Jones, A. Holmgren, and F.C. Kugelberg. Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results. Ther. Drug Monit. 29(2): 248-260 (2007).
3. E.W. Schwilke, M.I. Sampaio dos Santos, and B.K. Logan. Changing patterns of drug and alcohol use in fatally injured drivers in Washington State. J. Forens. Sci. 51(5): 1191-1198 (2006).
4. C. Moore and D. Lewis. Comment on oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J. Anal. Toxicol. 27(3): 169 (2003).
5. G.F. Kauert, S. Iwersen-Bergmannand, and S. Toennes. Assay of ?9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device. J. Anal. Toxicol. 30(4): 274-277 (2006).
6. P. Kintz and N. Samyn. Use of alternative specimens: drugs of abuse in saliva and doping agents in hair. Ther. Drug Monit. 24(2): 239-246 (2002).
7. O. Quintela, A. Cruz, A. de Castro, M. Concheiro, and M. Lopez-Rivadulla. Liquid chromatography-electrospray ionization mass spectrometry for the determination of nine selected benzodiazepines in human plasma and oral fluid. J. Chromatogr. 825: 63-71 (2005).
8. E.L. Oiestad, U. Johnsen, and A.S. Christophersen. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin. Chem. 53(2): 300-309 (2007).
9. B.E. Smink, M.P.M Mathijssen, K.J. Lusthof, J.J. de Gier, A.C.G. Egberts, and D.R.A. Uges. Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS). J. Anal. Toxicol. 30: 478-485 (2006).
10. 9-tetrahydrocannabinol (THC) in oral fluid using the Quantisal collection device. Forensic Sci. Int. 164(2-3): 126-130 (2006).
11. 9-tetra-hydrocannabinol-9-carboxylic acid (THCA), in oral fluid specimens. J. Anal. Toxicol. 30(7): 409-412 (2006).
12. C. Moore, S. Rana, and C. Coulter. Determination of meperidine, tramadol and oxycodone in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. J. Chromatogr. B 850: 370-375 (2007).
13. S. Rana, C. Moore, A. Agrawal, C. Coulter, M. Vincent, and J. Soares. Determination of propoxyphene in oral fluid. J. Anal. Toxicol. 30(8): 516-518 (2006).
14. O. Quintela, D. J. Crouch, and D.M. Andrenyak. Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device. J. Anal. Toxicol. 30(8): 614-616 (2006).
15. N. Samyn, G. de Boeck, V. Cirimele, A. Verstraete, and P. Kintz. Detection of flunitrazepam and 7-aminoflunitrazepam in oral fluid after controlled administration of Rohypnol. J. Anal. Toxicol. 26(4): 211-215 (2002).